Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, Steven S., Patel, Nikunj K., Hotton, Gary R., O'Sullivan, Karen, McCarter, Renée, Bunnage, Martin, Brooks, David J., Svendsen, Clive N. +1 more·2003·Nature Medicine

DOI 10.1038/nm850

Cited by (1,000)

Items 101–200 of 1,000

An Alkaline Based Method for Generating Crystalline, Strong, and Shape Memory Polyvinyl Alcohol Biomaterials
Mohammad Ali Darabi, Ali Khosrozadeh, Ying Wang, Nureddin A. Ashammakhi, Halima Alem, Ahmet Erdem, Qiang Chang, Kaige Xu, Yuqing Liu, Gaoxing Luo et al. · 2020 · Advanced Science
The Scientific Basis for the Current Treatment of Parkinson's Disease
C. Warren Olanow · 2004 · Annual Review of Medicine
Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies
Ji, Bin, Maeda, Jun, Sawada, Makoto, Ono, Maiko, Okauchi, Takashi, Inaji, Motoki, Zhang, Ming-Rong, Suzuki, Kazutoshi, Ando, Kiyoshi, Staufenbiel, Matthias et al. · 2008 · The Journal of Neuroscience
Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates
Soshana P. Behrstock, Allison D. Ebert, Jacalyn McHugh, Steven K. Vosberg, Jeannette M. Moore, Bernard Laurent Schneider, Elizabeth E. Capowski, Derek J. Hei, Jeffrey H. Kordower, Patrick Aebischer et al. · 2005 · Gene Therapy
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
Vincent Ries, Claire Henchcliffe, Tatyana Kareva, Margarita Rzhetskaya, Ross J. Bland, Matthew J. During, Nikolai G. Kholodilov, Robert E. Burke · 2006 · Proceedings of the National Academy of Sciences
Present and future drug treatment for Parkinson's disease
Anthony H.V. Schapira · 2005 · Journal of Neurology Neurosurgery & Psychiatry
Deep Brain Stimulation for Parkinson’s Disease
Patricia Dowsey Limousin, Irene Martínez‐Torres · 2008 · Neurotherapeutics
Applications of positron emission tomography (PET) in neurology
Y. Tai, P. Piccini · 2004 · Journal of Neurology Neurosurgery & Psychiatry
Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluid
Patricia Dickson, Michael F. McEntee, Carole A. Vogler, Steven Q. Le, Beth K. Levy, Maryn Peinovich, Stephen Hanson, Merry B. Passage, Emil Kakkis · 2007 · Molecular Genetics and Metabolism
Treatment of Parkinson’s Disease with Trophic Factors
Amie L. Peterson, John G. Nutt · 2008 · Neurotherapeutics
Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease
Allison D. Ebert, Amy J. Beres, Amelia E. Barber, Clive Niels Svendsen · 2007 · Experimental Neurology
Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial
Robert E. Gross, R.L. Watts, Robert A. Hauser, Roy A.E. Bakay, Heinz Reichmann, Rüdiger von Kummer, William G. Ondo, Elke Reissig, Wilhelm E. Eisner, Heike Steiner-Schulze et al. · 2011 · The Lancet Neurology
Enteric glial cells and their role in the intestinal epithelial barrier
Yanbo Yu · 2014 · World Journal of Gastroenterology
Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial
Robert H. Baloh, J. Patrick Johnson, Pablo Avalos, Peggy Allred, Soshana P. Svendsen, Genevíève Gowing, Kristina Roxas, Amanda Wu, Becky Donahue, Sheryl Osborne et al. · 2022 · Nature Medicine
Evaluation of animal models of Parkinson's disease for neuroprotective strategies
Marina Elena Emborg · 2004 · Journal of Neuroscience Methods
Regeneration of human auditory nerve. In vitro/in video demonstration of neural progenitor cells in adult human and guinea pig spiral ganglion
Helge Rask‐Andersen, Marja Boström, Bengt Gerdin, Anders Kinnefors, Gunnar Nyberg, Thomas Engstrand, Josef M. Miller, Dan Lindholm · 2005 · Hearing Research
Neurotrophic factor therapy for Parkinson’s disease
Suresh Babu Rangasamy, Katherine E. Soderstrom, Roy A.E. Bakay, Jeffrey H. Kordower · 2010 · Progress in brain research
Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson’s disease
Sun, Mei, Kong, Lingxin, Wang, Xiaodan, Lu, Xiu-gui, Gao, Qingsheng, Geller, Alfred I. · 2005 · Brain Research
Striatal Delivery of Neurturin by CERE-120, an AAV2 Vector for the Treatment of Dopaminergic Neuron Degeneration in Parkinson's Disease
Mehdi Gasmi, Christopher D. Herzog, Eugene P. Brandon, Justine J. Cunningham, G. Anthony Ramirez, Elias T. Ketchum, Raymond T. Bartus · 2006 · Molecular Therapy
A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
Shams S. M. Tabrez, Nasimudeen R. Jabir, Shazi Shakil, Nigel H. Greig, Qamre Alam, Adel Mohammed Abuzenadah, Ghazi Damanhouri, Mohammad Amjad Kamal · 2012 · CNS & Neurological Disorders - Drug Targets
Overexpression of Glial Cell Line-Derived Neurotrophic Factor Using a Lentiviral Vector Induces Time- and Dose-Dependent Downregulation of Tyrosine Hydroxylase in the Intact Nigrostriatal Dopamine System
Biljana Georgievska, Deniz Kirik, Anders Björklund · 2004 · Journal of Neuroscience
Effective GDNF brain delivery using microspheres—A promising strategy for Parkinson's disease
Garbayo, E., Montero-Menei, C.N., Ansorena, E., Lanciego, J.L., Aymerich, M.S., Blanco-Prieto, M.J. · 2009 · Journal of Controlled Release
Extrastriatal dopaminergic circuits of the basal ganglia
Karen S. Rommelfanger · 2010 · Frontiers in Neuroanatomy
Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
Amaal AlDakheel, Lorraine V. Kalia, Anthony Edward Lang · 2013 · Neurotherapeutics
Imaging in Parkinson's disease: the role of monoamines in behavior.
D. Brooks, P. Piccini · 2006 · Biological Psychiatry
Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors
Ubhi, Kiren, Rockenstein, Edward, Mante, Michael, Inglis, Chandra, Adame, Anthony, Patrick, Christina, Whitney, Kristen, Masliah, Eliezer · 2010 · The Journal of Neuroscience
The Neurotrophic Factor Artemin Promotes Pancreatic Cancer Invasion
G ralp O. Ceyhan, Nathalia A. Giese, Mert Erkan, Annika G. Kerscher, Moritz N. Wente, Thomas Giese, Markus W. B chler, Helmut Frieß · 2006 · Annals of Surgery
Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease
Robert Mark Richardson, Adrian P. Kells, Kathryn Hammond Rosenbluth, Ernesto A. Salegio, Massimo S. Fiandaca, Paul Larson, Philip A. Starr, Alastair J. Martin, Russell R. Lonser, Howard J. Federoff et al. · 2011 · Molecular Therapy
Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
Milota Kaluzová, Alexandros Bouras, Revaz Machaidze, Costas G. Hadjipanayis · 2015 · Oncotarget
Pericyte-derived Glial Cell Line-derived Neurotrophic Factor Increase the Expression of Claudin-5 in the Blood–brain Barrier and the Blood-nerve Barrier
Fumitaka Shimizu, Yasuteru Sano, Kazuyuki Saito, Masaaki Abe, Toshihiko Maeda, Hiroyo Haruki, Takashi Kanda · 2011 · Neurochemical Research
Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease
Merja H. Voutilainen, Susanne Bäck, Johan Peränen, Päivi Lindholm, Atso Raasmaja, Pekka T. Männistö, Märt Saarma, Raimo K. Tuominen · 2010 · Experimental Neurology
Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?
Olle Lindvall, Lars U. Wahlberg · 2007 · Experimental Neurology
AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: Long-term efficacy and tolerability of CERE-120 for Parkinson’s disease
Mehdi Gasmi, Eugene P. Brandon, Christopher D. Herzog, Alistair Wilson, Kathie M. Bishop, Eva K. Hofer, Justine J. Cunningham, Marie A. Printz, Jeffrey H. Kordower, Raymond T. Bartus · 2007 · Neurobiology of Disease
Image-Guided Convection-Enhanced Delivery Platform in the Treatment of Neurological Diseases
Massimo S. Fiandaca, John Forsayeth, Peter J. Dickinson, Krystof S. Bankiewicz · 2008 · Neurotherapeutics
Prediction of convection-enhanced drug delivery to the human brain
Andreas A. Linninger, Mahadevabharath R. Somayaji, Megan Mekarski, Libin Zhang · 2007 · Journal of Theoretical Biology
Emerging restorative treatments for Parkinson's disease
Tomas Deierborg, Denis Soulet, Laurent Roybon, Vanessa Jane Hall, Patrik Brundin · 2008 · Progress in Neurobiology
The Promise of Neuroprotective Agents in Parkinson?s Disease
Stacey E. Seidl, Judith A. Potashkin · 2011 · Frontiers in Neurology
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges
Kang, Lin, Jin, Shilin, Wang, Jiayi, Lv, Zhongyue, Xin, Chengqi, Tan, Chengcheng, Zhao, Mengke, Wang, Liang, Liu, Jing · 2023 · Journal of Controlled Release
Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor
Ding, Yun Min, Jaumotte, Juliann D., Signore, Armando P., Zigmond, Michael J. · 2004 · Journal of Neurochemistry
Striatal delivery of CERE‐120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys
Christopher D. Herzog, Biplob Dass, James E. Holden, James Stansell, Mehdi Gasmi, Mark H. Tuszynski, Raymond T. Bartus, Jeffrey H. Kordower · 2007 · Movement Disorders
GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop
Roger A. Barker, Anders Björklund, Don Marshall Gash, Alan L. Whone, Amber D. Van Laar, Jeffrey H. Kordower, Krystof S. Bankiewicz, Karl D. Kieburtz, Märt Saarma, Sigrid Booms et al. · 2020 · Journal of Parkinson s Disease
Influences of dopaminergic lesion on epidermal growth factor‐ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons
Yuriko Iwakura, Ying‐shan Piao, Makoto Mizuno, Nobuyuki Takei, Akiyoshi Kakita, Hitoshi Takahashi, Hiroyuki Nawa · 2005 · Journal of Neurochemistry
CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice
Mikko Airavaara, Brandon K. Harvey, Merja H. Voutilainen, Hui Shen, Jenny Chou, Päivi Lindholm, Maria Lindahl, Raimo K. Tuominen, Märt Saarma, Barry J. Hoffer et al. · 2011 · Cell Transplantation
Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson’s Disease
Sara Hernando, Enara Herrán, Joana Figueiro‐Silva, José Luís Pedraz, Manoli Igartúa, Eva Carro, Rosa Marı́a Hernández · 2017 · Molecular Neurobiology
Nanomedicine and drug delivery systems in cancer and regenerative medicine
Elisa Garbayo, Simon Pascual‐Gil, Carlos Rodríguez‐Nogales, Laura Saludas, Ander Estella‐Hermoso de Mendoza, María J. Blanco‐Prieto · 2020 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
Adrian P. Kells, Jamie L. Eberling, Xiao Su, Phillip Pivirotto, John Bringas, Piotr Hadaczek, Wade C. Narrow, William J. Bowers, Howard J. Federoff, John Forsayeth et al. · 2010 · Journal of Neuroscience
Overexpression of Heme Oxygenase-1 Protects Dopaminergic Neurons against 1-Methyl-4-Phenylpyridinium-Induced Neurotoxicity
Shih‐Ya Hung, Houng‐Chi Liou, Kai‐Hsiang Kang, Ruey‐Meei Wu, Chun-Chiang Wen, Wen Fu · 2008 · Molecular Pharmacology
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease
Fabio Fumagalli, Giorgio Racagni, Marco Andrea Riva · 2006 · The Pharmacogenomics Journal
Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson’s disease
Ayşe Ulusoy, Mickaël Decressac, Deniz Kirik, Anders Björklund · 2010 · Progress in brain research
What the future holds for deep brain stimulation
Alim Louis Benabid · 2007 · Expert Review of Medical Devices
Imaging neurodegeneration in Parkinson's disease
Nicola Pavese, David James Brooks · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s Disease
Alan L. Whone, Marciana Ionela Boca, Matthias Luz, Max Woolley, Lucy Mooney, Sonali Dharia, Jack Broadfoot, David Cronin, Christian Schroers, Neil U. Barua et al. · 2019 · Journal of Parkinson s Disease
Calcitriol Protection against Dopamine Loss Induced by Intracerebroventricular Administration of 6-Hydroxydopamine
Michael P. Smith, Anita M. Fletcher, David M. Yurek, Wayne A. Cass · 2006 · Neurochemical Research
Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease
Christophe Lo Bianco, Nicole Déglon, W F Pralong, Patrick Aebischer · 2004 · Neurobiology of Disease
Trophic Factor Gene Therapy for Parkinson's Disease
Jeffrey H. Kordower, Anders Björklund · 2013 · Movement Disorders
Convection‐Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations
Neil U. Barua, Steven S. Gill, Seth Love · 2013 · Brain Pathology
INTRACEREBRAL INFUSATE DISTRIBUTION BY CONVECTION-ENHANCED DELIVERY IN HUMANS WITH MALIGNANT GLIOMAS
John Howard Sampson, Martin Brady, Neil A. Petry, David J. Croteau, Allan H. Friedman, Henry S. Friedman, Terence Z. Wong, Darell D. Bigner, Ira H Pastan, Raj K. Puri et al. · 2007 · Operative Neurosurgery
Direct Estimation of Kinetic Parametric Images for Dynamic PET
Guobao Wang, Jinyi Qi · 2013 · Theranostics
Repairing the parkinsonian brain with neurotrophic factors
Liviu Aron, Rüdiger Klein · 2010 · Trends in Neurosciences
Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders
Ronald J. Mandel, Fredric P. Manfredsson, Kevin D. Foust, Aaron C. Rising, Sharon Reimsnider, Kevin R. Nash, Corinna Bürger · 2006 · Molecular Therapy
Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor
CHEN, Y, AI, Y, SLEVIN, J, MALEY, B, GASH, D · 2005 · Experimental Neurology
Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration
Tadahiro Numakawa, Tomoya Matsumoto, Yumiko Numakawa, Misty Richards, Shigeto Yamawaki, Hiroshi Kunugi · 2011 · Journal of Toxicology
From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)
Claire Géral, Angelina Angelova, Sylviane Lesieur · 2013 · Pharmaceutics
Neurorescue effects of VEGF on a rat model of Parkinson's disease
Takao Yasuhara, Tetsuro Shingo, Kenichiro Muraoka, Masahiro Kameda, Takashi Agari, Yuan Ji, Hitoshi Hayase, Hirofumi Hamada, Cesar V. Borlongan, Isao Date · 2005 · Brain Research
In vitro study of GDNF release from biodegradable PLGA microspheres
Anne Aubert‐Pouëssel, Marie‐Claire Venier‐Julienne, Anne Clavreul, Michelle Sergent, Christophe Jollivet, Claudia N. Montero‐Menei, Emmanuel Garcion, David C. Bibby, Philippe Meneï, Jean‐Pierre Benoît · 2004 · Journal of Controlled Release
Exercise: Is it a neuroprotective and if so, how does it work?
Michael J. Zigmond, Richard Jay Smeyne · 2013 · Parkinsonism & Related Disorders
Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats
Marı́a Pertusa, Silvia García‐Matas, Hamid Mammeri, Albert Adell, Teresa Rodrigo, Jacques J. Mallet, Rosa M. Cristòfol, Chamsy Sarkis, Coral Sanfeliu · 2007 · Neurobiology of Aging
Saxagliptin: A novel antiparkinsonian approach
Noha Nagah Nassar, Muhammad Y. Al‐Shorbagy, Hany H. Arab, Dalaal M. Abdallah · 2014 · Neuropharmacology
Granulocyte‐colony stimulating factor is neuroprotective in a model of Parkinson's disease
Katrin Meuer, Claudia Pitzer, Peter Teismann, Carola Krüger, Bettina Göricke, Rico Laage, Paul Lingor, Kerstin Peters, Johannes C. M. Schlachetzki, Kazuto Kobayashi et al. · 2006 · Journal of Neurochemistry
Axonal degeneration as a therapeutic target in the CNS
Lingor, Paul, Koch, Jan C., Tönges, Lars, Bähr, Mathias · 2012 · Cell and Tissue Research
Biocompatibility of poly(ethylene glycol)‐based hydrogels in the brain: An analysis of the glial response across space and time
Kimberly B. Bjugstad, Kyle J. Lampe, Drew S. Kern, Melissa J. Mahoney · 2010 · Journal of Biomedical Materials Research Part A
Dopamine D3 receptor‐preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons
Fang Du, Rui Li, Yuan‐Gui Huang, Xuping Li, Weidong Le · 2005 · European Journal of Neuroscience
Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand ?
Henriques · 2010 · Frontiers in Neuroscience
Dynamic single photon emission computed tomography—basic principles and cardiac applications
Grant T. Gullberg, B.W. Reutter, Arkadiusz Sitek, Jonathan S. Maltz, Thomas F. Budinger · 2010 · Physics in Medicine and Biology
Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease
Yu Zhang, I‐Wei Wu, Shannon T. Buckley, Christopher S. Coffey, Eric Foster, Susan Mendick, John Peter Seibyl, Norbert W. Schuff · 2015 · Movement Disorders
SURGERY FOR MOVEMENT DISORDERS
Ali R. Rezai, André G. Machado, Milind S. Deogaonkar, Hooman Azmi, Cynthia S. Kubu, Nicholas M. Boulis · 2008 · Neurosurgery
Novel perspectives of neural stem cell differentiation: From neurotransmitters to therapeutics
Cleber A. Trujillo, Telma T. Schwindt, Antonio Henrique B. Martins, Janaína M. Alves, Luiz E. Mello, Henning Ulrich · 2008 · Cytometry Part A
Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity
Jagdeep K. Sandhu, Mossa Gardaneh, Rafal M. Iwasiow, Patricia H. Lanthier, Sandhya Gangaraju, Maria Ribecco‐Lutkiewicz, Roger G. Tremblay, Kazutoshi Kiuchi, Marianna Sikorska · 2008 · Neurobiology of Disease
Regulated Delivery of Glial Cell Line-Derived Neurotrophic Factor into Rat Striatum, Using a Tetracycline-Dependent Lentiviral Vector
Biljana Georgievska, Johan Jakobsson, Elisabeth B. Persson, Cecilia Ericson, Deniz Kirik, Cecilia Lundberg · 2004 · Human Gene Therapy
Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery
Vanja Varenika, Peter J. Dickinson, John Bringas, Richard A. LeCouteur, Robert Higgins, John B. Park, Massimo S. Fiandaca, Mitchel Stuart Berger, John Howard Sampson, Krystof S. Bankiewicz · 2008 · Journal of neurosurgery
N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-κB transcription factor
Wakako Maruyama, Atusmi Nitta, Masayo Shamoto‐Nagai, Yoko Hirata, Yukihiro Akao, Moussa Yodim, Shoei Furukawa, Toshitaka Nabeshima, Makoto Naoi · 2003 · Neurochemistry International
Vitamin D Receptor Gene as a Candidate Gene for Parkinson Disease
Megan W. Butler, Amber Burt, Todd L. Edwards, Stephan L. Zuchner, William K. Scott, Eden R. Martin, Jeffery M. Vance, Liyong Wang · 2011 · Annals of Human Genetics
Novel targeted therapies for Parkinson’s disease
Theodora Ntetsika, Paraskevi-Evita Papathoma, Ioanna Markaki · 2021 · Molecular Medicine
Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease
Mark H. Tuszynski, Armin Blesch · 2004 · Progress in brain research
A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra
HeatherA . Boger, L.D. Middaugh, Peng Huang, Vandana Zaman, A SMITH, Barry J. Hoffer, A. Tomac, Ann‐Charlotte Granholm · 2006 · Experimental Neurology
Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra
Michael F. Salvatore, Jin‐Lu Zhang, Delia M. Large, Patsy E. Wilson, Clelland R. Gash, Theresa Currier Thomas, John W. Haycock, Guoying Bing, John A. Stanford, Don Marshall Gash et al. · 2004 · Journal of Neurochemistry
Driving GDNF expression: The green and the red traffic lights
Ana Saavedra, Graça Baltazar, Emı́lia P. Duarte · 2008 · Progress in Neurobiology
Generalized Algorithms for Direct Reconstruction of Parametric Images From Dynamic PET Data
Guobao Wang, Jinyi Qi · 2009 · IEEE Transactions on Medical Imaging
Reprint: Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys
David N. Hovland, Robert B. Boyd, Mark T. Butt, Jeffery A. Engelhardt, Michael S. Moxness, Mark H. Ma, Maurice G. Emery, Nadia B. Ernst, Randall P. Reed, Jillynne R. Zeller et al. · 2007 · Toxicologic Pathology
AAV transduction of dopamine neurons with constitutively active rheb protects from neurodegeneration and mediates axon regrowth
Kim, Sang Ryong, Kareva, Tatyana, Yarygina, Olga, Kholodilov, Nikolai, Burke, Robert E · 2012 · Molecular Therapy
The blood-brain barrier and nasal drug delivery to the central nervous system
Miyake, Marcel Menon, Bleier, Benjamin S. · 2015 · American Journal of Rhinology & Allergy
A Large-Scale Interface for Optogenetic Stimulation and Recording in Nonhuman Primates
Azadeh Yazdan-Shahmorad, Camilo A. Diaz-Botia, Timothy Hanson, Viktor Kharazia, Peter Ledochowitsch, Michel M. Maharbiz, Philip N. Sabes · 2016 · Neuron
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
Marika Alborghetti, Ferdinando Nicoletti · 2018 · Current Neuropharmacology
Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study
Adolfo Mínguez‐Castellanos, Francisco Escamilla Sevilla, Gary R. Hotton, Juan José Toledo‐Aral, A Ortega-Moreno, Simón Méndez‐Ferrer, José María Martín‐Linares, Majed Jouma Katati, Pablo Mir, Javier Villadiego et al. · 2007 · Journal of Neurology Neurosurgery & Psychiatry
Enhanced Delivery and Bioactivity of the Neurturin Neurotrophic Factor through Focused Ultrasound—Mediated Blood—Brain Barrier Opening in vivo
Gesthimani Samiotaki, Camilo Acosta, Shutao Wang, Elisa E. Konofagou · 2015 · Journal of Cerebral Blood Flow & Metabolism
Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives
Yousra El Ouaamari, Jasper Van den Bos, Barbara M. P. Willekens, Nathalie Cools, Inez Wens · 2023 · International Journal of Molecular Sciences
Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease
Anthony Edward Lang, Jose Angel Obeso · 2004 · Annals of Neurology
RET Is Dispensable for Maintenance of Midbrain Dopaminergic Neurons in Adult Mice
Sanjay R. Jain, Judith P. Golden, David F. Wozniak, Elizabeth A. Pehek, Eugene M. Johnson, Jeffrey Milbrandt · 2006 · Journal of Neuroscience
Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
Lijuan Hou, Wei Chen, Xiaoli Liu, Decai Qiao, Fu-Ming Zhou · 2017 · Frontiers in Aging Neuroscience
Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus)
Andisheh Eslamboli, Rosalyn M. Cummings, Rosalind M. Ridley, H. F. Baker, Nicholas Muzyczka, Corinna Bürger, Ronald J. Mandel, Deniz Kirik, Lucy E. Annett · 2003 · Experimental Neurology